cefuroxime has been researched along with Acute Disease in 110 studies
Cefuroxime: Broad-spectrum cephalosporin antibiotic resistant to beta-lactamase. It has been proposed for infections with gram-negative and gram-positive organisms, GONORRHEA, and HAEMOPHILUS.
cefuroxime : A 3-(carbamoyloxymethyl)cephalosporin compound having a 7-(2Z)-2-(furan-2-yl)-2-(methoxyimino)acetamido side chain.
Acute Disease: Disease having a short and relatively severe course.
| Excerpt | Relevance | Reference |
|---|---|---|
| "A randomized clinical trial, comparing the efficacy of two oral antibiotics, cefuroxime and co-amoxiclav in the treatment of acute sinusitis, was conducted in 2007." | 9.16 | Comparison of cefuroxime and co-amoxiclav in the treatment of acute sinusitis in a sample of the Iranian population. ( Alaghehbandan, R; Alinejad, F; Asghari, B; Gholami, A; Lari, AR; Mostafavi, H, 2012) |
| "A randomized, double-blind, double-dummy trial was performed comparing 200 mg of cefditoren-pivoxil twice daily for 5 days versus standard cefuroxime-axetil treatment (250 mg twice daily for 10 days) of Anthonisen type I or II acute exacerbations of chronic bronchitis." | 9.12 | Clinical and bacteriological efficacy in treatment of acute exacerbations of chronic bronchitis with cefditoren-pivoxil versus cefuroxime-axetil. ( Aguilar, L; Alvarez-Sala, JL; Coronel, P; Kardos, P; Martínez-Beltrán, J, 2006) |
| "To compare the efficacy and safety of faropenem medoxomil, 300 mg twice daily for seven or ten days, with cefuroxime axetil 250 mg twice daily for ten days in adults with acute bacterial sinusitis (ABS)." | 9.12 | Randomized double-blind study comparing 7- and 10-day regimens of faropenem medoxomil with a 10-day cefuroxime axetil regimen for treatment of acute bacterial sinusitis. ( Echols, R; Kowalsky, S; Rosemore, M; Tosiello, R; Upchurch, J, 2006) |
| "To compare the effectiveness of oral moxifloxacin with standard antibiotic therapy in acute exacerbation of chronic bronchitis (AECB)." | 9.11 | Short-term and long-term outcomes of moxifloxacin compared to standard antibiotic treatment in acute exacerbations of chronic bronchitis. ( Allegra, L; Huchon, G; Izquierdo, JL; Jones, P; Sagnier, PP; Schaberg, T; Wilson, R, 2004) |
| "A 10-d course of cefuroxime axetil offered no clinical benefit to children with an acute respiratory illness and imaging evidence of acute sinusitis." | 9.11 | Cefuroxime axetil versus placebo for children with acute respiratory infection and imaging evidence of sinusitis: a randomized, controlled trial. ( Alho, OP; Ilkko, E; Koivunen, P; Kristo, A; Luotonen, J; Uhari, M, 2005) |
| " To evaluate that hypothesis, 25 patients with acute pyelonephritis of Gram-negative aetiology were given intravenous cefuroxime 1." | 9.09 | Impact of cefuroxime administration on endotoxin (LPS) and tumour necrosis factor-alpha (TNFalpha) blood levels in patients suffering from acute pyelonephritis: a preliminary report. ( Eoconomou, E; Giamarellou, H; Giamarellou-Bourboulis, EJ; Lelekis, M; Perdios, J; Tsouroulas, P, 1999) |
| "The aim of this multicentre, randomized study was to compare the efficacy and safety of moxifloxacin (BAY 12-8039), a new 8-methoxy fluoroquinolone, with that of cefuroxime axetil for the treatment of acute bacterial sinusitis in adults." | 9.09 | A comparison of the safety and efficacy of moxifloxacin (BAY 12-8039) and cefuroxime axetil in the treatment of acute bacterial sinusitis in adults. The Sinusitis Study Group. ( Bagger-Sjöbäck, D; Gehanno, P; Hampel, B; Ibanez, JM; Nikolaidis, P; Siegert, R; Sommerauer, B, 2000) |
| " (4 x 300 mg, day 1-14), cefuroxime (CAS 55268-75-2) (2 x 250 mg daily for day 1-6), ambroxol (CAS 18683-91-5) (3 x 30 mg for day 1-3, 2 x 30 mg for days 4-14) and matched placebo in acute bronchitis." | 9.09 | Efficacy and tolerability of myrtol standardized in acute bronchitis. A multi-centre, randomised, double-blind, placebo-controlled parallel group clinical trial vs. cefuroxime and ambroxol. ( Carls, C; de Mey, C; Geib, A; Matthys, H; Ryś, A; Wittig, T, 2000) |
| "To compare the efficacy, safety and cost of cefuroxime and cephradine in the treatment of acute pyelonephritis in pregnancy." | 9.09 | [Prospective, randomized, comparative study of the efficacy, safety and cost of cefuroxime versus cephradine in acute pyelonephritis during pregnancy]. ( Cona, E; Lobos, L; Martínez, MA; Ovalle, A; Valderrama, O; Villablanca, E; Wolff, M, 2000) |
| "The addition of fluticasone to xylometazoline and antimicrobial therapy with cefuroxime improves clinical success rates and accelerates recovery of patients with a history of chronic rhinitis or recurrent sinusitis who present for treatment of acute rhinosinusitis." | 9.09 | Comparison of cefuroxime with or without intranasal fluticasone for the treatment of rhinosinusitis. The CAFFS Trial: a randomized controlled trial. ( Califf, RM; Dolor, RJ; Hellkamp, AS; Simel, DL; Williams, JW; Witsell, DL, 2001) |
| "Five hundred thirty-seven patients were enrolled in two independent, investigator-blinded, multicenter, randomized clinical trials comparing the clinical and bacteriologic efficacies and the safety of 5- or 10-day treatment with cefuroxime axetil with those of 10-day treatment with amoxicillin-clavulanate in the treatment of secondary bacterial infections of acute bronchitis." | 9.08 | Effectiveness of short-course therapy (5 days) with cefuroxime axetil in treatment of secondary bacterial infections of acute bronchitis. ( Collins, JJ; Drehobl, M; Giguere, G; Henry, D; Puopolo, A; Rhudy, J; Ruoff, GE; Schoenberger, J, 1995) |
| "In a double-blind, multicentre trial, 382 patients with a diagnosis of acute purulent sinusitis were randomised to receive sparfloxacin 200 mg once daily for 5 days following a loading dose of 400 mg on day 1 (n = 193) or cefuroxime axetil 250 mg twice daily for 8 days (n = 189)." | 9.08 | Sparfloxacin versus cefuroxime axetil in the treatment of acute purulent sinusitis. Sinusitis Study Group. ( Berche, P; Gehanno, P, 1996) |
| " We conducted two independent, investigator-blinded, multicenter, randomized clinical trials, one of which included microbiologic evaluation of middle ear fluid obtained by tympanocentesis, comparing the efficacy and safety of 5 or 10 days of treatment with cefuroxime axetil suspension (CAE) with that of 10 days of treatment with amoxicillin/clavulanate suspension (AMX/CL) in children with acute otitis media." | 9.08 | Effectiveness of five days of therapy with cefuroxime axetil suspension for treatment of acute otitis media. ( Blair, E; Collins, JJ; Giguere, GG; Gooch, WM; Miller, HC; Paster, RZ; Puopolo, A; Schwartz, RH; Smyre, HL; Yetman, R, 1996) |
| "In this open, single center study, the concentration of cefuroxime achieved in the serum and middle ear effusion of pediatric acute otitis media patients with purulent effusion was assessed between 2 and 5 h after a single oral dose of 15 mg/kg cefuroxime axetil suspension." | 9.08 | Concentration of cefuroxime in middle ear effusion of children with acute otitis media. ( Efthymiopoulos, C; Marr, C; Thorarinsson, H; Thoroddsen, E, 1997) |
| "This study compared the use and efficacy of ciprofloxacin to cefuroxime axetil for adult patients with acute bacterial sinusitis." | 9.08 | Ciprofloxacin versus cefuroxime axetil in the treatment of adult patients with acute bacterial sinusitis. ( Echols, RM; Heyd, A; Klein, GL; Whalen, E, 1998) |
| "In a prospective, multicenter, double-blind study, the interval to clinical relapse in patients with acute bacterial exacerbations of chronic bronchitis from whom a pretherapy pathogen was isolated was compared following treatment with ciprofloxacin or cefuroxime axetil." | 9.08 | Randomized, double-blind study of ciprofloxacin and cefuroxime axetil for treatment of acute bacterial exacerbations of chronic bronchitis. The Bronchitis Study Group. ( Aneiro, L; Chodosh, S; Drehobl, M; Farkas, S; Kowalsky, S; McCarty, J; Shan, M; Tosiello, R, 1998) |
| "Cefuroxime axetil was evaluated for clinical efficacy and tolerance in the treatment of acute otitis media in children." | 9.07 | Cefuroxime axetil in the treatment of acute otitis media in children. ( Beratis, NG; Goumas, PD; Haliotis, FA; Lygatsikas, CG; Spyropoulos, CD; Syrogiannopoulos, GA, 1992) |
| "Three hundred seventeen patients with clinical and radiographic evidence of acute maxillary sinusitis were enrolled at nine centers and were randomly assigned to receive 10 days of treatment with cefuroxime axetil 250 mg twice daily (n = 157) or amoxicillin/clavulanate 500 mg three times daily (n = 160)." | 9.07 | Clinical comparison of cefuroxime axetil and amoxicillin/clavulanate in the treatment of patients with acute bacterial maxillary sinusitis. ( Camacho, AE; Cobo, R; Collins, JJ; Garrison, NA; Giguere, GC; Lerner, CJ; Miniti, A; Mydlow, PK; Otte, J; Spector, SL, 1992) |
| "Eighty-five patients were randomly allocated to receive either piperacillin (n = 38) or cefuroxime plus metronidazole (n = 45) after surgical treatment of diffuse peritonitis; 78 were evaluable." | 9.07 | Piperacillin compared with cefuroxime plus metronidazole in diffuse peritonitis. ( Alhava, EM; Huttunen, R; Karjalainen, K; Lahtinen, J; Miettinen, P; Paakkonen, M; Silvola, H; Viitanen, J, 1991) |
| "The aim of this multicenter, prospective randomized trial was to compare the efficacy and safety of cefuroxime-axetil and amoxycillin/clavulanic acid for the treatment of infectious bronchitis in the elderly patient." | 9.06 | [Ambulatory treatment with cefuroxime-axetil of infectious bronchitis in patients sixty years of age or older: comparative study of the combination of amoxicillin and clavulanic acid]. ( Chiche, D; Hugonot, L; Hugonot, R; Pappo, M, 1990) |
| "In this randomized, blinded, multicenter comparison study, 377 infants and children with acute otitis media (AOM) received a 10-day course of an oral suspension of one of the following: cefuroxime axetil (CAE), 30 mg/kg/day; cefaclor (CEC), 40 mg/kg/day; or amoxicillin-clavulanate potassium (AMX-CL), 40 mg/kg/day." | 9.06 | Comparison of cefuroxime axetil, cefaclor, and amoxicillin-clavulanate potassium suspensions in acute otitis media in infants and children. ( Aronovitz, GH; Darden, PM; Gooch, WM; Johnson, C; Maddern, B; McLinn, SE; Pichichero, M, 1990) |
| "Eighty-nine college women with acute urinary tract infections were treated orally with either 1,000 mg of cefuroxime axetil in a single dose (n = 59) or 250 mg of cefaclor three times a day for 7 days (n = 30)." | 9.06 | Single-dose cefuroxime axetil versus multiple-dose cefaclor in the treatment of acute urinary tract infections. ( Iravani, A; Richard, GA, 1989) |
| "Cefuroxime axetil was compared with cefaclor for the therapy for lower respiratory tract infections." | 9.06 | Blinded comparison of cefuroxime to cefaclor for lower respiratory tract infections. ( Anthony, WC; Craig, W; File, TM; Lifland, P; Schleupner, CJ; Tan, J; Vogelman, B, 1988) |
| "Cefuroxime axetil is a beta-lactamase-stable, second-generation, oral cephalosporin that penetrates sinus tissue in concentrations exceeding the MIC90 values (the minimum concentration of drug needed to inhibit the growth of 90% of an isolate of a particular microorganism) for pathogens most commonly associated with acute sinusitis, including Streptococcus pneumoniae and Haemophilus influenzae." | 8.79 | Cefuroxime axetil in the treatment of sinusitis. A review. ( Collins, JJ; Graham, JA; Pakes, GE; Rauch, AM, 1994) |
| "This study was performed to compare the therapeutic efficacy of cefuroxime with that of cefotaxime as initial antimicrobial therapies in women with complicated nonobstructive acute pyelonephritis (APN) caused by Enterobacteriaceae infections." | 7.81 | Propensity-matched analysis to compare the therapeutic efficacies of cefuroxime versus cefotaxime as initial antimicrobial therapy for community-onset complicated nonobstructive acute pyelonephritis due to Enterobacteriaceae infection in women. ( Chang, UI; Kim, HW; Wie, SH, 2015) |
| "A method for quantitative determination of cefuroxime in mixed saliva of patients with sinusitis by using spectrophotometer Shimadzu UV-1800, combined with the IBM PC is described." | 7.80 | [Study on pharmacokinetics of cefuroxime by dynamics of its distribution in oral fluid of patients with sinusitis]. ( Kulapina, OI; Mikhailova, MS, 2014) |
| "To study the influence of resistance phenotypes (based on sentinel antibiotics: penicillin and amoxicillin with/without clavulanate) on the cefuroxime versus cefditoren susceptibility of Streptococcus pneumoniae and Haemophilus influenzae recovered from children with acute otitis media." | 7.74 | Influence of the beta-lactam resistance phenotype on the cefuroxime versus cefditoren susceptibility of Streptococcus pneumoniae and Haemophilus influenzae recovered from children with acute otitis media. ( Aguilar, L; Coronel, P; Fenoll, A; Giménez, MJ; Gimeno, M; Granizo, JJ; Robledo, O; Tarragó, D, 2007) |
| "With telithromycin up to 22 Euros by patient with acute exacerbation of chronic bronchitis could be saved, in comparison with cefuroxime-axetil." | 7.72 | [Pharmacoeconomic analysis of patients with acute exacerbation of chronic bronchitis treated with telithromycin or cefuroxime-axetil]. ( Chang, J; Cots, JM; Domínguez-Gil, A; Herreras, A; Rubio-Terrés, C; Sánchez Gascón, F; Trilla, A, 2004) |
| "The aim of the study was to substantiate clinically and microbiologically administration of such oral cephalosporins as cefuroxime axetil and ceftibuten in acute sinusitis." | 7.71 | [Comparative clinical efficacy and tolerance of cefuroxime axetil (zinnat) and ceftibuten (cedex) in patients with acute sinusitis]. ( Kamanin, EI; Kozlov, SN; Otvagin, IV; Strachunskiĭ, LS, 2001) |
| "The comparative efficacies of amoxicillin and cefuroxime against acute otitis media caused by a penicillin-resistant (MIC, 2 micrograms/ml) Streptococcus pneumoniae strain were assessed in a gerbil model by challenging each ear with 10(7) bacteria through transbullar instillation." | 7.70 | In vivo efficacies of amoxicillin and cefuroxime against penicillin-resistant Streptococcus pneumoniae in a gerbil model of acute otitis media. ( Aguilar, L; Cenjor, C; García-Calvo, G; Giménez, MJ; Nieto, E; Parra, A; Ponte, C; Soriano, F, 1998) |
| "Amoxicillin, cefpodoxime and cefuroxime MICs remained low against numerous penicillin resistant strains, indicating that these three oral antibiotics (in combination with clavulanate for amoxicillin) have a useful potential for the treatment of acute otitis media when risk factors for pneumococcal penicillin-resistant infections are detected." | 7.70 | [Development of resistance to beta-lactams and other antibiotics of pneumococci isolated from acute otitis media in France: statement of the National Reference Center 1995-1996]. ( Fremaux, A; Georges, S; Geslin, P; Sissia, G; Spicq, C, 1998) |
| " The study was undertaken to determine the concentrations of cefuroxime in the blood and middle ear effusions (MEE) of children between 6 and 12 years of age with acute otitis media and chronic OME after a single oral dose administration of cefuroxime axetil, the ester prodrug of cefuroxime." | 7.68 | Concentration of cefuroxime in serum and middle ear effusion after single dose treatment with cefuroxime axetil. ( Bluestone, CD; Collins, JJ; Haddad, J; Hart, RW; Isaacson, G; Respler, DS; Yilmaz, HM, 1991) |
| "Cefuroxime axetil, a new beta-lactamase-stable cephalosporin, was compared with cefaclor for the treatment of acute bacterial maxillary sinusitis in 106 adult patients." | 7.67 | Comparative evaluation of cefuroxime axetil and cefaclor for treatment of acute bacterial maxillary sinusitis. ( Cocchetto, DM; Gwaltney, JM; Scheld, WM; Sydnor, A, 1989) |
| "Cefuroxime axetil in a single daily dose of 250 mg for ten days was given to 75 women with symptoms of acute uncomplicated urinary tract infections." | 7.67 | Treatment of acute uncomplicated urinary tract infections with single daily doses of cefuroxime axetil. ( Harris, K; Joy, GE; Leigh, DA; Tait, S; Walsh, B, 1989) |
| "The pharmacokinetics of cefuroxime was studied in 40 pregnant women with acute pyelonephritis." | 7.67 | [Pharmacokinetics of cefuroxime in pregnant women with acute pyelonephritis]. ( Akhtamova, ZM; Dorokhov, VV; Khokholov, LE; Voropaeva, SD, 1985) |
| "Sixty-five patients, 25 with acute bronchopulmonary respiratory tract diseases and 40 with acute exacerbations of chronic respiratory tract infections, were treated by means of intramuscular injection of an extempore combination of 1 g of cefuroxime and 300 mg of acetylcysteine." | 7.67 | Acute and exacerbated chronic respiratory tract infections: treatment with a combination of cefuroxime and acetylcysteine. ( Dal Negro, RW; Pomari, C; Trevisan, F; Turco, P; Zoccatelli, O, 1985) |
| "Acute maxillary sinusitis is a common condition requiring broad-spectrum therapy to prevent development of chronic disease." | 6.69 | Cefuroxime axetil versus clarithromycin in the treatment of acute maxillary sinusitis. ( Jablonicky, P; Jacovides, A; Sedani, S; Staley, H; Stefansson, P, 1998) |
| "Moxifloxacin was found to be similar in effectiveness to cefuroxime axetil at the end-of-therapy visit (90% vs." | 6.69 | Comparison of moxifloxacin and cefuroxime axetil in the treatment of acute maxillary sinusitis. Sinusitis Infection Study Group. ( Burke, T; Church, D; Haverstock, D; Heyd, A; Huck, W; Mariano, H; Orchard, D; Villanueva, C, 1999) |
| "A regimen of cefprozil (500 mg twice daily), a new oral cephalosporin with a broad in vitro spectrum of antimicrobial activity, was compared to standard regimens of cefaclor (500 mg three times daily), cefuroxime axetil (500 mg twice daily), or amoxicillin/clavulanate (500 mg/125 mg three times daily) for the treatment of lower respiratory tract infections (mainly bronchitis and acute exacerbations of chronic bronchitis) in adults in three open-label, randomized trials." | 6.17 | Review of the experience with cefprozil for the treatment of lower respiratory tract infections. ( Pelletier, LL, 1992) |
| " Recent work has led to the development of cefuroxime axetil (CXM-AX, SN407) which is the 1-acetoxyethyl ester of CXM is well absorbed from the gastrointestinal tract and promptly cleaved to cefuroxime thereafter." | 5.27 | [Clinical studies on cefuroxime axetil in acute mastitis]. ( Hashimoto, I; Mikami, J; Nakamura, T; Sawada, Y, 1987) |
| "A randomized clinical trial, comparing the efficacy of two oral antibiotics, cefuroxime and co-amoxiclav in the treatment of acute sinusitis, was conducted in 2007." | 5.16 | Comparison of cefuroxime and co-amoxiclav in the treatment of acute sinusitis in a sample of the Iranian population. ( Alaghehbandan, R; Alinejad, F; Asghari, B; Gholami, A; Lari, AR; Mostafavi, H, 2012) |
| "A randomized, double-blind, double-dummy trial was performed comparing 200 mg of cefditoren-pivoxil twice daily for 5 days versus standard cefuroxime-axetil treatment (250 mg twice daily for 10 days) of Anthonisen type I or II acute exacerbations of chronic bronchitis." | 5.12 | Clinical and bacteriological efficacy in treatment of acute exacerbations of chronic bronchitis with cefditoren-pivoxil versus cefuroxime-axetil. ( Aguilar, L; Alvarez-Sala, JL; Coronel, P; Kardos, P; Martínez-Beltrán, J, 2006) |
| "To compare the efficacy and safety of faropenem medoxomil, 300 mg twice daily for seven or ten days, with cefuroxime axetil 250 mg twice daily for ten days in adults with acute bacterial sinusitis (ABS)." | 5.12 | Randomized double-blind study comparing 7- and 10-day regimens of faropenem medoxomil with a 10-day cefuroxime axetil regimen for treatment of acute bacterial sinusitis. ( Echols, R; Kowalsky, S; Rosemore, M; Tosiello, R; Upchurch, J, 2006) |
| "To compare the effectiveness of oral moxifloxacin with standard antibiotic therapy in acute exacerbation of chronic bronchitis (AECB)." | 5.11 | Short-term and long-term outcomes of moxifloxacin compared to standard antibiotic treatment in acute exacerbations of chronic bronchitis. ( Allegra, L; Huchon, G; Izquierdo, JL; Jones, P; Sagnier, PP; Schaberg, T; Wilson, R, 2004) |
| "A 10-d course of cefuroxime axetil offered no clinical benefit to children with an acute respiratory illness and imaging evidence of acute sinusitis." | 5.11 | Cefuroxime axetil versus placebo for children with acute respiratory infection and imaging evidence of sinusitis: a randomized, controlled trial. ( Alho, OP; Ilkko, E; Koivunen, P; Kristo, A; Luotonen, J; Uhari, M, 2005) |
| " To evaluate that hypothesis, 25 patients with acute pyelonephritis of Gram-negative aetiology were given intravenous cefuroxime 1." | 5.09 | Impact of cefuroxime administration on endotoxin (LPS) and tumour necrosis factor-alpha (TNFalpha) blood levels in patients suffering from acute pyelonephritis: a preliminary report. ( Eoconomou, E; Giamarellou, H; Giamarellou-Bourboulis, EJ; Lelekis, M; Perdios, J; Tsouroulas, P, 1999) |
| "This double-masked, multicenter, randomized clinical trial compared the efficacy and tolerability of cefuroxime axetil and amoxicillin/clavulanate in the treatment of acute bacterial maxillary sinusitis." | 5.09 | Comparison of cefuroxime axetil and amoxicillin/clavulanate in the treatment of acute bacterial sinusitis. ( Allen, J; Burroughs, S; Cobb, MM; Henry, DC; Holley, HP; Settipane, GA; Sydnor, A, 1999) |
| "The aim of this multicentre, randomized study was to compare the efficacy and safety of moxifloxacin (BAY 12-8039), a new 8-methoxy fluoroquinolone, with that of cefuroxime axetil for the treatment of acute bacterial sinusitis in adults." | 5.09 | A comparison of the safety and efficacy of moxifloxacin (BAY 12-8039) and cefuroxime axetil in the treatment of acute bacterial sinusitis in adults. The Sinusitis Study Group. ( Bagger-Sjöbäck, D; Gehanno, P; Hampel, B; Ibanez, JM; Nikolaidis, P; Siegert, R; Sommerauer, B, 2000) |
| " (4 x 300 mg, day 1-14), cefuroxime (CAS 55268-75-2) (2 x 250 mg daily for day 1-6), ambroxol (CAS 18683-91-5) (3 x 30 mg for day 1-3, 2 x 30 mg for days 4-14) and matched placebo in acute bronchitis." | 5.09 | Efficacy and tolerability of myrtol standardized in acute bronchitis. A multi-centre, randomised, double-blind, placebo-controlled parallel group clinical trial vs. cefuroxime and ambroxol. ( Carls, C; de Mey, C; Geib, A; Matthys, H; Ryś, A; Wittig, T, 2000) |
| "To compare the efficacy, safety and cost of cefuroxime and cephradine in the treatment of acute pyelonephritis in pregnancy." | 5.09 | [Prospective, randomized, comparative study of the efficacy, safety and cost of cefuroxime versus cephradine in acute pyelonephritis during pregnancy]. ( Cona, E; Lobos, L; Martínez, MA; Ovalle, A; Valderrama, O; Villablanca, E; Wolff, M, 2000) |
| "The addition of fluticasone to xylometazoline and antimicrobial therapy with cefuroxime improves clinical success rates and accelerates recovery of patients with a history of chronic rhinitis or recurrent sinusitis who present for treatment of acute rhinosinusitis." | 5.09 | Comparison of cefuroxime with or without intranasal fluticasone for the treatment of rhinosinusitis. The CAFFS Trial: a randomized controlled trial. ( Califf, RM; Dolor, RJ; Hellkamp, AS; Simel, DL; Williams, JW; Witsell, DL, 2001) |
| "Five hundred thirty-seven patients were enrolled in two independent, investigator-blinded, multicenter, randomized clinical trials comparing the clinical and bacteriologic efficacies and the safety of 5- or 10-day treatment with cefuroxime axetil with those of 10-day treatment with amoxicillin-clavulanate in the treatment of secondary bacterial infections of acute bronchitis." | 5.08 | Effectiveness of short-course therapy (5 days) with cefuroxime axetil in treatment of secondary bacterial infections of acute bronchitis. ( Collins, JJ; Drehobl, M; Giguere, G; Henry, D; Puopolo, A; Rhudy, J; Ruoff, GE; Schoenberger, J, 1995) |
| "In a double-blind, multicentre trial, 382 patients with a diagnosis of acute purulent sinusitis were randomised to receive sparfloxacin 200 mg once daily for 5 days following a loading dose of 400 mg on day 1 (n = 193) or cefuroxime axetil 250 mg twice daily for 8 days (n = 189)." | 5.08 | Sparfloxacin versus cefuroxime axetil in the treatment of acute purulent sinusitis. Sinusitis Study Group. ( Berche, P; Gehanno, P, 1996) |
| " We conducted two independent, investigator-blinded, multicenter, randomized clinical trials, one of which included microbiologic evaluation of middle ear fluid obtained by tympanocentesis, comparing the efficacy and safety of 5 or 10 days of treatment with cefuroxime axetil suspension (CAE) with that of 10 days of treatment with amoxicillin/clavulanate suspension (AMX/CL) in children with acute otitis media." | 5.08 | Effectiveness of five days of therapy with cefuroxime axetil suspension for treatment of acute otitis media. ( Blair, E; Collins, JJ; Giguere, GG; Gooch, WM; Miller, HC; Paster, RZ; Puopolo, A; Schwartz, RH; Smyre, HL; Yetman, R, 1996) |
| " pneumoniae is associated with an impaired bacteriologic and clinical response of acute otitis media to cefaclor and cefuroxime axetil." | 5.08 | Impaired bacteriologic response to oral cephalosporins in acute otitis media caused by pneumococci with intermediate resistance to penicillin. ( Abramson, O; Dagan, R; Fliss, DM; Goshen, S; Greenberg, D; Lang, R; Leiberman, A; Leibovitz, E; Yagupsky, P, 1996) |
| "Bacteriologic response to cefuroxime axetil and cefaclor administered for 10 days was evaluated in acute otitis media (AOM) in patients aged 6-36 months." | 5.08 | Bacteriologic response to oral cephalosporins: are established susceptibility breakpoints appropriate in the case of acute otitis media? ( Abramson, O; Dagan, R; Fliss, DM; Goshen, S; Greenberg, D; Lang, R; Leiberman, A; Leibovitz, E; Yagupsky, P, 1997) |
| "In this open, single center study, the concentration of cefuroxime achieved in the serum and middle ear effusion of pediatric acute otitis media patients with purulent effusion was assessed between 2 and 5 h after a single oral dose of 15 mg/kg cefuroxime axetil suspension." | 5.08 | Concentration of cefuroxime in middle ear effusion of children with acute otitis media. ( Efthymiopoulos, C; Marr, C; Thorarinsson, H; Thoroddsen, E, 1997) |
| "This study compared the use and efficacy of ciprofloxacin to cefuroxime axetil for adult patients with acute bacterial sinusitis." | 5.08 | Ciprofloxacin versus cefuroxime axetil in the treatment of adult patients with acute bacterial sinusitis. ( Echols, RM; Heyd, A; Klein, GL; Whalen, E, 1998) |
| "In a prospective, multicenter, double-blind study, the interval to clinical relapse in patients with acute bacterial exacerbations of chronic bronchitis from whom a pretherapy pathogen was isolated was compared following treatment with ciprofloxacin or cefuroxime axetil." | 5.08 | Randomized, double-blind study of ciprofloxacin and cefuroxime axetil for treatment of acute bacterial exacerbations of chronic bronchitis. The Bronchitis Study Group. ( Aneiro, L; Chodosh, S; Drehobl, M; Farkas, S; Kowalsky, S; McCarty, J; Shan, M; Tosiello, R, 1998) |
| "Cefuroxime axetil was evaluated for clinical efficacy and tolerance in the treatment of acute otitis media in children." | 5.07 | Cefuroxime axetil in the treatment of acute otitis media in children. ( Beratis, NG; Goumas, PD; Haliotis, FA; Lygatsikas, CG; Spyropoulos, CD; Syrogiannopoulos, GA, 1992) |
| "Three hundred seventeen patients with clinical and radiographic evidence of acute maxillary sinusitis were enrolled at nine centers and were randomly assigned to receive 10 days of treatment with cefuroxime axetil 250 mg twice daily (n = 157) or amoxicillin/clavulanate 500 mg three times daily (n = 160)." | 5.07 | Clinical comparison of cefuroxime axetil and amoxicillin/clavulanate in the treatment of patients with acute bacterial maxillary sinusitis. ( Camacho, AE; Cobo, R; Collins, JJ; Garrison, NA; Giguere, GC; Lerner, CJ; Miniti, A; Mydlow, PK; Otte, J; Spector, SL, 1992) |
| "Eighty-five patients were randomly allocated to receive either piperacillin (n = 38) or cefuroxime plus metronidazole (n = 45) after surgical treatment of diffuse peritonitis; 78 were evaluable." | 5.07 | Piperacillin compared with cefuroxime plus metronidazole in diffuse peritonitis. ( Alhava, EM; Huttunen, R; Karjalainen, K; Lahtinen, J; Miettinen, P; Paakkonen, M; Silvola, H; Viitanen, J, 1991) |
| "To evaluate objectively clinical efficacy, safety and usefulness of cefuroxime axetil (CXM-AX) in acute dental infections (periodontitis, pericoronitis and gnathitis), we carried out a comparison study using cefaclor (CCL) as the control." | 5.06 | [Clinical evaluation of cefuroxime axetil in acute dental infections. Double blind comparative study vs. cefaclor]. ( Fukuoka, F; Hara, H; Kaneko, A; Michi, K; Morihana, T; Ohne, M; Sasaki, I; Satoh, T; Takahashi, K; Yoshinari, N, 1990) |
| "The aim of this multicenter, prospective randomized trial was to compare the efficacy and safety of cefuroxime-axetil and amoxycillin/clavulanic acid for the treatment of infectious bronchitis in the elderly patient." | 5.06 | [Ambulatory treatment with cefuroxime-axetil of infectious bronchitis in patients sixty years of age or older: comparative study of the combination of amoxicillin and clavulanic acid]. ( Chiche, D; Hugonot, L; Hugonot, R; Pappo, M, 1990) |
| "In this randomized, blinded, multicenter comparison study, 377 infants and children with acute otitis media (AOM) received a 10-day course of an oral suspension of one of the following: cefuroxime axetil (CAE), 30 mg/kg/day; cefaclor (CEC), 40 mg/kg/day; or amoxicillin-clavulanate potassium (AMX-CL), 40 mg/kg/day." | 5.06 | Comparison of cefuroxime axetil, cefaclor, and amoxicillin-clavulanate potassium suspensions in acute otitis media in infants and children. ( Aronovitz, GH; Darden, PM; Gooch, WM; Johnson, C; Maddern, B; McLinn, SE; Pichichero, M, 1990) |
| "Eighty-nine college women with acute urinary tract infections were treated orally with either 1,000 mg of cefuroxime axetil in a single dose (n = 59) or 250 mg of cefaclor three times a day for 7 days (n = 30)." | 5.06 | Single-dose cefuroxime axetil versus multiple-dose cefaclor in the treatment of acute urinary tract infections. ( Iravani, A; Richard, GA, 1989) |
| "Cefuroxime axetil and cefaclor were compared for efficacy in the treatment of acute otitis media with effusion." | 5.06 | Treatment of otitis media with cefuroxime axetil. ( Aronovitz, GH, 1988) |
| "Cefuroxime axetil was compared with cefaclor for the therapy for lower respiratory tract infections." | 5.06 | Blinded comparison of cefuroxime to cefaclor for lower respiratory tract infections. ( Anthony, WC; Craig, W; File, TM; Lifland, P; Schleupner, CJ; Tan, J; Vogelman, B, 1988) |
| "To compare the efficacy and tolerability of a 5-day course of telithromycin (800 mg once daily) with a 10-day course of telithromycin or standard comparators (amoxicillin-clavulanate 500/125 mg three times daily or cefuroxime axetil 250 mg twice daily) in patients with acute maxillary sinusitis (AMS)." | 4.82 | Clinical and bacteriological efficacy of 5-day telithromycin in acute maxillary sinusitis: a pooled analysis. ( Baz, M; Leroy, B; Rangaraju, M; Roos, K; Tellier, G, 2005) |
| " As an example, a study comparing 5 days of cefuroxime axetil therapy with either 10 days of cefuroxime axetil or amoxycillin/clavulanate showed no differences in rates of clinical cure, bacteriological eradication and recurrence in paediatric patients with either acute otitis media or sinusitis." | 4.80 | Short courses of antibiotic in acute otitis media and sinusitis infections. ( Pichicero, M, 2000) |
| "Cefuroxime axetil is a beta-lactamase-stable, second-generation, oral cephalosporin that penetrates sinus tissue in concentrations exceeding the MIC90 values (the minimum concentration of drug needed to inhibit the growth of 90% of an isolate of a particular microorganism) for pathogens most commonly associated with acute sinusitis, including Streptococcus pneumoniae and Haemophilus influenzae." | 4.79 | Cefuroxime axetil in the treatment of sinusitis. A review. ( Collins, JJ; Graham, JA; Pakes, GE; Rauch, AM, 1994) |
| "The current case suggests that acute macular edema with serous retinal detachment after cataract surgery with standard cefuroxime prophylaxis can occur even in vitrectomized eyes." | 4.02 | ACUTE MACULAR EDEMA WITH SEROUS RETINAL DETACHMENT AFTER CATARACT SURGERY IN A VITRECTOMIZED EYE: A CASE REPORT. ( Brems, RN; Bryan, EA; Bryan, JS; Cruz-Iñigo, YJ, 2021) |
| "This study was performed to compare the therapeutic efficacy of cefuroxime with that of cefotaxime as initial antimicrobial therapies in women with complicated nonobstructive acute pyelonephritis (APN) caused by Enterobacteriaceae infections." | 3.81 | Propensity-matched analysis to compare the therapeutic efficacies of cefuroxime versus cefotaxime as initial antimicrobial therapy for community-onset complicated nonobstructive acute pyelonephritis due to Enterobacteriaceae infection in women. ( Chang, UI; Kim, HW; Wie, SH, 2015) |
| "A method for quantitative determination of cefuroxime in mixed saliva of patients with sinusitis by using spectrophotometer Shimadzu UV-1800, combined with the IBM PC is described." | 3.80 | [Study on pharmacokinetics of cefuroxime by dynamics of its distribution in oral fluid of patients with sinusitis]. ( Kulapina, OI; Mikhailova, MS, 2014) |
| "To study the influence of resistance phenotypes (based on sentinel antibiotics: penicillin and amoxicillin with/without clavulanate) on the cefuroxime versus cefditoren susceptibility of Streptococcus pneumoniae and Haemophilus influenzae recovered from children with acute otitis media." | 3.74 | Influence of the beta-lactam resistance phenotype on the cefuroxime versus cefditoren susceptibility of Streptococcus pneumoniae and Haemophilus influenzae recovered from children with acute otitis media. ( Aguilar, L; Coronel, P; Fenoll, A; Giménez, MJ; Gimeno, M; Granizo, JJ; Robledo, O; Tarragó, D, 2007) |
| "With telithromycin up to 22 Euros by patient with acute exacerbation of chronic bronchitis could be saved, in comparison with cefuroxime-axetil." | 3.72 | [Pharmacoeconomic analysis of patients with acute exacerbation of chronic bronchitis treated with telithromycin or cefuroxime-axetil]. ( Chang, J; Cots, JM; Domínguez-Gil, A; Herreras, A; Rubio-Terrés, C; Sánchez Gascón, F; Trilla, A, 2004) |
| "The aim of the study was to substantiate clinically and microbiologically administration of such oral cephalosporins as cefuroxime axetil and ceftibuten in acute sinusitis." | 3.71 | [Comparative clinical efficacy and tolerance of cefuroxime axetil (zinnat) and ceftibuten (cedex) in patients with acute sinusitis]. ( Kamanin, EI; Kozlov, SN; Otvagin, IV; Strachunskiĭ, LS, 2001) |
| "The comparative efficacies of amoxicillin and cefuroxime against acute otitis media caused by a penicillin-resistant (MIC, 2 micrograms/ml) Streptococcus pneumoniae strain were assessed in a gerbil model by challenging each ear with 10(7) bacteria through transbullar instillation." | 3.70 | In vivo efficacies of amoxicillin and cefuroxime against penicillin-resistant Streptococcus pneumoniae in a gerbil model of acute otitis media. ( Aguilar, L; Cenjor, C; García-Calvo, G; Giménez, MJ; Nieto, E; Parra, A; Ponte, C; Soriano, F, 1998) |
| "Amoxicillin, cefpodoxime and cefuroxime MICs remained low against numerous penicillin resistant strains, indicating that these three oral antibiotics (in combination with clavulanate for amoxicillin) have a useful potential for the treatment of acute otitis media when risk factors for pneumococcal penicillin-resistant infections are detected." | 3.70 | [Development of resistance to beta-lactams and other antibiotics of pneumococci isolated from acute otitis media in France: statement of the National Reference Center 1995-1996]. ( Fremaux, A; Georges, S; Geslin, P; Sissia, G; Spicq, C, 1998) |
| "The efficacy of amoxicillin/clavulanate and cefuroxime was determined in a gerbil model of otitis media with a mixed Streptococcus pneumoniae plus Haemophilus influenzae middle ear (ME) infection." | 3.70 | Role of Streptococcus pneumoniae and Haemophilus influenzae in the development of acute otitis media and otitis media with effusion in a gerbil model. ( Aguilar, L; Cenjor, C; García-Calvo, G; Giménez, MJ; Nieto, E; Parra, A; Ponte, C; Soriano, F, 2000) |
| " Children over 2 are treated by amoxicillin or CG1, children with conjunctivitis are treated by amoxicillin + clavulanate acid, infants attending day care centers and with recent history of antibiotic treatment have to be treated by cefuroxim-axetil, cefpodoximproxetil or high dosages of amoxicillin." | 3.70 | [Treatment of acute otitis media in children]. ( François, M, 1998) |
| "Eighty-four children suffering from acute otitis media caused by Streptococcus pneumoniae were treated prospectively with cefuroxime axetil suspension (30 mg/kg of body weight twice daily for 8 days)." | 3.69 | In vivo correlates for Streptococcus pneumoniae penicillin resistance in acute otitis media. ( Berche, P; Gehanno, P; Lenoir, G, 1995) |
| " The study was undertaken to determine the concentrations of cefuroxime in the blood and middle ear effusions (MEE) of children between 6 and 12 years of age with acute otitis media and chronic OME after a single oral dose administration of cefuroxime axetil, the ester prodrug of cefuroxime." | 3.68 | Concentration of cefuroxime in serum and middle ear effusion after single dose treatment with cefuroxime axetil. ( Bluestone, CD; Collins, JJ; Haddad, J; Hart, RW; Isaacson, G; Respler, DS; Yilmaz, HM, 1991) |
| "Cefuroxime axetil, a new beta-lactamase-stable cephalosporin, was compared with cefaclor for the treatment of acute bacterial maxillary sinusitis in 106 adult patients." | 3.67 | Comparative evaluation of cefuroxime axetil and cefaclor for treatment of acute bacterial maxillary sinusitis. ( Cocchetto, DM; Gwaltney, JM; Scheld, WM; Sydnor, A, 1989) |
| "Cefuroxime axetil in a single daily dose of 250 mg for ten days was given to 75 women with symptoms of acute uncomplicated urinary tract infections." | 3.67 | Treatment of acute uncomplicated urinary tract infections with single daily doses of cefuroxime axetil. ( Harris, K; Joy, GE; Leigh, DA; Tait, S; Walsh, B, 1989) |
| "The pharmacokinetics of cefuroxime was studied in 40 pregnant women with acute pyelonephritis." | 3.67 | [Pharmacokinetics of cefuroxime in pregnant women with acute pyelonephritis]. ( Akhtamova, ZM; Dorokhov, VV; Khokholov, LE; Voropaeva, SD, 1985) |
| "Sixty-five patients, 25 with acute bronchopulmonary respiratory tract diseases and 40 with acute exacerbations of chronic respiratory tract infections, were treated by means of intramuscular injection of an extempore combination of 1 g of cefuroxime and 300 mg of acetylcysteine." | 3.67 | Acute and exacerbated chronic respiratory tract infections: treatment with a combination of cefuroxime and acetylcysteine. ( Dal Negro, RW; Pomari, C; Trevisan, F; Turco, P; Zoccatelli, O, 1985) |
| " The serum concentrations of cefuroxime were found to be above the minimal inhibitory concentration (MIC) for penicillin-sensitive Streptococcus pneumoniae for 100% of the dosing interval and 42% of the time for intermediate-resistant strains." | 2.69 | Measuring antibiotic levels in otitis media. ( Thoroddsen, E, 1998) |
| "Acute maxillary sinusitis is a common condition requiring broad-spectrum therapy to prevent development of chronic disease." | 2.69 | Cefuroxime axetil versus clarithromycin in the treatment of acute maxillary sinusitis. ( Jablonicky, P; Jacovides, A; Sedani, S; Staley, H; Stefansson, P, 1998) |
| "Moxifloxacin was found to be similar in effectiveness to cefuroxime axetil at the end-of-therapy visit (90% vs." | 2.69 | Comparison of moxifloxacin and cefuroxime axetil in the treatment of acute maxillary sinusitis. Sinusitis Infection Study Group. ( Burke, T; Church, D; Haverstock, D; Heyd, A; Huck, W; Mariano, H; Orchard, D; Villanueva, C, 1999) |
| "Cefuroxime was given by i." | 2.67 | Cefuroxime efficacy in pneumonia: sequential short-course i.v./oral suspension therapy. ( Cuningham, K; Dagan, R; Engelhard, D; Ephros, M; Shalit, I, 1994) |
| "Nonoperative treatment of acute diverticulitis with extraluminal air is safe and effective in patients with a small amount of distant intraperitoneal air or pericolic air without clinical signs of peritonitis." | 1.40 | Nonoperative management of perforated diverticulitis with extraluminal air is safe and effective in selected patients. ( Leppäniemi, AK; Mentula, PJ; Sallinen, VJ, 2014) |
| "Early treatment of profound bilateral sensorineural hearing loss with cochlear implantation has become routine, resulting in an increased proportion of children implanted at younger ages." | 1.39 | The management of acute mastoiditis in children with cochlear implants: saving the device. ( Cushing, SL; Gordon, KA; James, AL; Osborn, HA; Papsin, BC, 2013) |
| "We found a high prevalence of acute dacryocystitis as a potential cause of the cellulitis." | 1.33 | [Preseptal and orbital cellulitis in childhood: response to intravenous antibiotics]. ( Abelairas-Gómez, J; Alberto, MJ; Boto-de-los-Bueis, A; Durán-Giménez-Rico, MC; Gabarrón-Hermosilla, MI; González-Iglesias, MJ, 2005) |
| "Acute mastoiditis is the most frequent intratemporal complication of otitis media." | 1.32 | Acute mastoiditis caused by Moraxella catarrhalis. ( Jero, J; Leskinen, K, 2003) |
| "A sample of 2899 acute respiratory infections was studied (5." | 1.31 | Assessment of antibiotic prescription in acute respiratory infections in adults. The Spanish Study Group on Antibiotic Treatments. ( Eiros, JM; Guerra, L; Inglada, L; Ochoa, C; Vallano, A, 2000) |
| "Acute otitis media is treated with antibiotics in 93% of the cases diagnosed in Spanish hospitals." | 1.31 | The variability and appropriateness of the antibiotic prescription of acute otitis media in childhood. The Spanish Study Group for Antibiotic Treatments. ( Ochoa, C; Pérez Méndez, C; Solís, G, 2000) |
| "Acute Lyme arthritis may mimic acute pyogenic arthritis." | 1.29 | Acute arthritis of the hip in a child infected with the Lyme spirochete. ( Eppes, SC; Miller, A; Stanton, RP, 1993) |
| " From the clinical and pharmacokinetic data a dosage of 1." | 1.27 | Cefuroxime in acute septic arthritis. ( Hedström, SA; Lidgren, L; Nilsson-Ehle, I, 1984) |
| " Recent work has led to the development of cefuroxime axetil (CXM-AX, SN407) which is the 1-acetoxyethyl ester of CXM is well absorbed from the gastrointestinal tract and promptly cleaved to cefuroxime thereafter." | 1.27 | [Clinical studies on cefuroxime axetil in acute mastitis]. ( Hashimoto, I; Mikami, J; Nakamura, T; Sawada, Y, 1987) |
| "Preceding trauma was found in 27 and/or associated diseases (e." | 1.27 | Predisposing factors, bacteriology and antibiotic therapy in 35 cases of septic bursitis. ( Hedström, SA; Söderquist, B, 1986) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 18 (16.36) | 18.7374 |
| 1990's | 48 (43.64) | 18.2507 |
| 2000's | 33 (30.00) | 29.6817 |
| 2010's | 10 (9.09) | 24.3611 |
| 2020's | 1 (0.91) | 2.80 |
| Authors | Studies |
|---|---|
| Bosch-Nicolau, P | 1 |
| Falcó, V | 1 |
| Viñado, B | 1 |
| Andreu, A | 1 |
| Len, O | 1 |
| Almirante, B | 1 |
| Pigrau, C | 1 |
| Bryan, EA | 1 |
| Cruz-Iñigo, YJ | 1 |
| Brems, RN | 1 |
| Bryan, JS | 1 |
| Osborn, HA | 1 |
| Cushing, SL | 1 |
| Gordon, KA | 1 |
| James, AL | 1 |
| Papsin, BC | 1 |
| Sallinen, VJ | 1 |
| Mentula, PJ | 1 |
| Leppäniemi, AK | 1 |
| Al-Mazrou, KA | 1 |
| Shibl, AM | 1 |
| Kandeil, W | 1 |
| Pirçon, JY | 1 |
| Marano, C | 1 |
| Chang, UI | 1 |
| Kim, HW | 1 |
| Wie, SH | 1 |
| Kulapina, OI | 1 |
| Mikhailova, MS | 1 |
| Creuzot-Garcher, C | 1 |
| Benzenine, E | 1 |
| Mariet, AS | 1 |
| de Lazzer, A | 1 |
| Chiquet, C | 1 |
| Bron, AM | 1 |
| Quantin, C | 1 |
| Mitty, J | 1 |
| Margolius, D | 1 |
| Pezzilli, R | 1 |
| Kang, JH | 1 |
| Lee, SY | 1 |
| Kim, JH | 1 |
| Hur, JK | 1 |
| Lee, KY | 1 |
| García-Sáenz, MC | 1 |
| Arias-Puente, A | 1 |
| Rodríguez-Caravaca, G | 1 |
| Andrés Alba, Y | 1 |
| Bañuelos Bañuelos, J | 1 |
| Lari, AR | 1 |
| Alinejad, F | 1 |
| Alaghehbandan, R | 1 |
| Mostafavi, H | 1 |
| Asghari, B | 1 |
| Gholami, A | 1 |
| Weiss, LR | 1 |
| Leskinen, K | 1 |
| Jero, J | 1 |
| Zvulunov, A | 1 |
| Gal, N | 1 |
| Segev, Z | 1 |
| Siegert, R | 2 |
| Berg, O | 1 |
| Gehanno, P | 5 |
| Leiberman, A | 3 |
| Martinkenas, JL | 1 |
| Nikolaidis, P | 2 |
| Arvis, P | 1 |
| Alefelder, M | 1 |
| Reimnitz, P | 1 |
| Wilson, R | 1 |
| Allegra, L | 1 |
| Huchon, G | 1 |
| Izquierdo, JL | 1 |
| Jones, P | 1 |
| Schaberg, T | 1 |
| Sagnier, PP | 1 |
| Rubio-Terrés, C | 1 |
| Cots, JM | 1 |
| Domínguez-Gil, A | 1 |
| Herreras, A | 1 |
| Sánchez Gascón, F | 1 |
| Chang, J | 1 |
| Trilla, A | 1 |
| Lapienis, M | 1 |
| Powajbo, K | 1 |
| Gryczyńska, D | 1 |
| Roos, K | 1 |
| Tellier, G | 2 |
| Baz, M | 1 |
| Leroy, B | 1 |
| Rangaraju, M | 1 |
| Durán-Giménez-Rico, MC | 1 |
| Boto-de-los-Bueis, A | 1 |
| Alberto, MJ | 1 |
| González-Iglesias, MJ | 1 |
| Gabarrón-Hermosilla, MI | 1 |
| Abelairas-Gómez, J | 1 |
| Brunton, SA | 1 |
| Nusrat, R | 1 |
| Kristo, A | 1 |
| Uhari, M | 1 |
| Luotonen, J | 1 |
| Ilkko, E | 1 |
| Koivunen, P | 1 |
| Alho, OP | 1 |
| Stott, P | 1 |
| Das, R | 1 |
| Bingham, JS | 1 |
| Ridgway, G | 1 |
| Oriel, JD | 1 |
| Alvarez-Sala, JL | 1 |
| Kardos, P | 1 |
| Martínez-Beltrán, J | 1 |
| Coronel, P | 2 |
| Aguilar, L | 4 |
| Upchurch, J | 1 |
| Rosemore, M | 1 |
| Tosiello, R | 3 |
| Kowalsky, S | 2 |
| Echols, R | 1 |
| Fenoll, A | 1 |
| Robledo, O | 1 |
| Giménez, MJ | 3 |
| Tarragó, D | 1 |
| Granizo, JJ | 1 |
| Gimeno, M | 1 |
| Guérisse, P | 1 |
| Bello, CS | 1 |
| Fakunle, YM | 1 |
| Russ, C | 1 |
| Sarachian, B | 1 |
| Corthey, C | 1 |
| Stamboulian, D | 1 |
| Hedström, SA | 2 |
| Lidgren, L | 1 |
| Nilsson-Ehle, I | 1 |
| Nelson, JD | 1 |
| Bucholz, RW | 1 |
| Kusmiesz, H | 1 |
| Shelton, S | 1 |
| Tydén, G | 1 |
| Brattström, C | 1 |
| Malmborg, AS | 1 |
| Baudin, F | 1 |
| Ozier, Y | 1 |
| Sainio, V | 1 |
| Kemppainen, E | 1 |
| Puolakkainen, P | 1 |
| Taavitsainen, M | 1 |
| Kivisaari, L | 1 |
| Valtonen, V | 1 |
| Haapiainen, R | 1 |
| Schröder, T | 1 |
| Kivilaakso, E | 1 |
| Lenoir, G | 1 |
| Berche, P | 2 |
| Torkkeli, T | 1 |
| Ruoppi, P | 1 |
| Nuutinen, J | 1 |
| Kari, A | 1 |
| Pakes, GE | 1 |
| Graham, JA | 1 |
| Rauch, AM | 1 |
| Collins, JJ | 5 |
| Shalit, I | 1 |
| Dagan, R | 4 |
| Engelhard, D | 1 |
| Ephros, M | 1 |
| Cuningham, K | 1 |
| Miller, A | 1 |
| Stanton, RP | 1 |
| Eppes, SC | 1 |
| Gooch, WM | 3 |
| McLinn, SE | 2 |
| Aronovitz, GH | 3 |
| Pichichero, ME | 1 |
| Kumar, A | 1 |
| Kaplan, EL | 1 |
| Ossi, MJ | 1 |
| Zhang, B | 1 |
| Liu, Y | 1 |
| Wang, J | 1 |
| Wang, B | 1 |
| Henry, D | 1 |
| Ruoff, GE | 1 |
| Rhudy, J | 1 |
| Puopolo, A | 2 |
| Drehobl, M | 2 |
| Schoenberger, J | 1 |
| Giguere, G | 1 |
| Rünzi, M | 1 |
| Layer, P | 1 |
| Odeh, M | 1 |
| Oliven, A | 1 |
| Sautereau, D | 1 |
| Johnson, CD | 1 |
| Blair, E | 1 |
| Paster, RZ | 1 |
| Schwartz, RH | 1 |
| Miller, HC | 1 |
| Smyre, HL | 1 |
| Yetman, R | 1 |
| Giguere, GG | 1 |
| Abramson, O | 2 |
| Leibovitz, E | 3 |
| Lang, R | 2 |
| Goshen, S | 2 |
| Greenberg, D | 2 |
| Yagupsky, P | 2 |
| Fliss, DM | 2 |
| Bart, BIa | 1 |
| Solov'ev, SS | 1 |
| Zaseeva, OV | 1 |
| Benevskaia, VF | 1 |
| Mikhaĭlusova, MP | 1 |
| Romanova, MV | 1 |
| Kasatikova, LA | 1 |
| Mavrinac, JM | 1 |
| Dolan, RW | 1 |
| Thoroddsen, E | 3 |
| Marr, C | 2 |
| Efthymiopoulos, C | 1 |
| Thorarinsson, H | 1 |
| Harries, PG | 1 |
| Klein, GL | 1 |
| Whalen, E | 1 |
| Echols, RM | 2 |
| Heyd, A | 3 |
| Joseph, EM | 1 |
| Sperling, NM | 1 |
| Cenjor, C | 2 |
| Ponte, C | 2 |
| Parra, A | 2 |
| Nieto, E | 2 |
| García-Calvo, G | 2 |
| Soriano, F | 2 |
| Sheppard, DC | 1 |
| Chambers, HF | 1 |
| Olszewski, J | 2 |
| Zalewski, P | 1 |
| Markucki, S | 1 |
| Schmidt, J | 1 |
| Geslin, P | 1 |
| Fremaux, A | 1 |
| Sissia, G | 1 |
| Spicq, C | 1 |
| Georges, S | 1 |
| Chodosh, S | 1 |
| McCarty, J | 1 |
| Farkas, S | 1 |
| Shan, M | 2 |
| Aneiro, L | 1 |
| Stefansson, P | 1 |
| Jacovides, A | 1 |
| Jablonicky, P | 1 |
| Sedani, S | 1 |
| Staley, H | 1 |
| Johnson, PA | 1 |
| Rodriguez, HP | 1 |
| Wazen, JJ | 1 |
| Huck, W | 2 |
| Giamarellou-Bourboulis, EJ | 1 |
| Perdios, J | 1 |
| Lelekis, M | 1 |
| Eoconomou, E | 1 |
| Tsouroulas, P | 1 |
| Giamarellou, H | 1 |
| Anzueto, A | 1 |
| Rizzo, JA | 1 |
| Grossman, RF | 1 |
| Henry, DC | 1 |
| Sydnor, A | 2 |
| Settipane, GA | 1 |
| Allen, J | 1 |
| Burroughs, S | 1 |
| Cobb, MM | 1 |
| Holley, HP | 1 |
| Pessey, JJ | 1 |
| Machac, J | 1 |
| Pimentel, JM | 1 |
| Leblanc, F | 1 |
| Burke, T | 1 |
| Villanueva, C | 1 |
| Mariano, H | 1 |
| Orchard, D | 1 |
| Haverstock, D | 1 |
| Church, D | 1 |
| Bagger-Sjöbäck, D | 1 |
| Ibanez, JM | 1 |
| Hampel, B | 1 |
| Sommerauer, B | 1 |
| Ochoa, C | 2 |
| Eiros, JM | 1 |
| Inglada, L | 1 |
| Vallano, A | 1 |
| Guerra, L | 1 |
| Matthys, H | 1 |
| de Mey, C | 1 |
| Carls, C | 1 |
| Ryś, A | 1 |
| Geib, A | 1 |
| Wittig, T | 1 |
| Ovalle, A | 1 |
| Martínez, MA | 1 |
| Wolff, M | 1 |
| Cona, E | 1 |
| Valderrama, O | 1 |
| Villablanca, E | 1 |
| Lobos, L | 1 |
| Pichicero, M | 1 |
| Solís, G | 1 |
| Pérez Méndez, C | 1 |
| Rao, PP | 1 |
| Mopkar, O | 1 |
| Desai, A | 1 |
| Lund, B | 1 |
| Edlund, C | 1 |
| Rynnel-Dagöö, B | 1 |
| Lundgren, Y | 1 |
| Sterner, J | 1 |
| Nord, CE | 1 |
| Cronberg, S | 1 |
| Banke, S | 1 |
| Bergman, B | 1 |
| Boman, H | 1 |
| Eilard, T | 1 |
| Elbel, E | 1 |
| Hugo-Persson, M | 1 |
| Johansson, E | 1 |
| Kuylenstierna, N | 1 |
| Lanbeck, P | 1 |
| Lindblom, A | 1 |
| Paulsen, O | 1 |
| Schönbeck, C | 1 |
| Walder, M | 1 |
| Wieslander, P | 1 |
| Cohen, AD | 1 |
| Cagnano, E | 1 |
| Halevy, S | 1 |
| Otvagin, IV | 1 |
| Kamanin, EI | 1 |
| Strachunskiĭ, LS | 1 |
| Kozlov, SN | 1 |
| Woolhouse, IS | 1 |
| Hill, SL | 1 |
| Stockley, RA | 1 |
| Dolor, RJ | 1 |
| Witsell, DL | 1 |
| Hellkamp, AS | 1 |
| Williams, JW | 1 |
| Califf, RM | 1 |
| Simel, DL | 1 |
| François, M | 1 |
| Kuśmierczyk, K | 1 |
| Winn, RJ | 1 |
| Syrogiannopoulos, GA | 1 |
| Goumas, PD | 1 |
| Haliotis, FA | 1 |
| Lygatsikas, CG | 1 |
| Spyropoulos, CD | 1 |
| Beratis, NG | 1 |
| Camacho, AE | 1 |
| Cobo, R | 1 |
| Otte, J | 1 |
| Spector, SL | 1 |
| Lerner, CJ | 1 |
| Garrison, NA | 1 |
| Miniti, A | 1 |
| Mydlow, PK | 1 |
| Giguere, GC | 1 |
| Pelletier, LL | 1 |
| Paakkonen, M | 1 |
| Alhava, EM | 1 |
| Huttunen, R | 1 |
| Karjalainen, K | 1 |
| Lahtinen, J | 1 |
| Miettinen, P | 1 |
| Silvola, H | 1 |
| Viitanen, J | 1 |
| Haddad, J | 1 |
| Isaacson, G | 1 |
| Respler, DS | 1 |
| Hart, RW | 1 |
| Yilmaz, HM | 1 |
| Bluestone, CD | 1 |
| Sasaki, I | 1 |
| Morihana, T | 1 |
| Kaneko, A | 1 |
| Michi, K | 1 |
| Takahashi, K | 1 |
| Fukuoka, F | 1 |
| Satoh, T | 1 |
| Yoshinari, N | 1 |
| Ohne, M | 1 |
| Hara, H | 1 |
| Hugonot, R | 1 |
| Hugonot, L | 1 |
| Pappo, M | 1 |
| Chiche, D | 1 |
| Pichichero, M | 1 |
| Maddern, B | 1 |
| Johnson, C | 1 |
| Darden, PM | 1 |
| Becopoulos, T | 1 |
| Georgoulias, D | 1 |
| Constantinides, C | 1 |
| Stathakis, H | 1 |
| Kosmidis, J | 1 |
| Gwaltney, JM | 1 |
| Cocchetto, DM | 1 |
| Scheld, WM | 1 |
| Leigh, DA | 1 |
| Joy, GE | 1 |
| Tait, S | 1 |
| Harris, K | 1 |
| Walsh, B | 1 |
| Martínez Abad, M | 1 |
| Delgado Gomis, F | 1 |
| Morales-Olivas, FJ | 1 |
| Iravani, A | 1 |
| Richard, GA | 1 |
| Schleupner, CJ | 1 |
| Anthony, WC | 1 |
| Tan, J | 1 |
| File, TM | 1 |
| Lifland, P | 1 |
| Craig, W | 1 |
| Vogelman, B | 1 |
| Carson, JW | 1 |
| Watters, K | 1 |
| Taylor, MR | 1 |
| Keane, CT | 1 |
| Nakamura, T | 1 |
| Hashimoto, I | 1 |
| Sawada, Y | 1 |
| Mikami, J | 1 |
| Söderquist, B | 1 |
| Akhtamova, ZM | 1 |
| Khokholov, LE | 1 |
| Dorokhov, VV | 1 |
| Voropaeva, SD | 1 |
| Dal Negro, RW | 1 |
| Turco, P | 1 |
| Zoccatelli, O | 1 |
| Pomari, C | 1 |
| Trevisan, F | 1 |
7 reviews available for cefuroxime and Acute Disease
| Article | Year |
|---|---|
Updates and controversies in the treatment of Lyme disease.
Topics: Acute Disease; Amoxicillin; Anti-Bacterial Agents; Cefuroxime; Chronic Disease; Diagnosis, Different | 2008 |
Acute hematogenous osteomyelitis of the pelvis in childhood: Diagnostic clues and pitfalls.
Topics: Acute Disease; Anti-Bacterial Agents; Blood; Cefuroxime; Child; Humans; Male; Osteomyelitis; Pelvic | 2003 |
Clinical and bacteriological efficacy of 5-day telithromycin in acute maxillary sinusitis: a pooled analysis.
Topics: Acute Disease; Adolescent; Adult; Aged; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacteria | 2005 |
Telithromycin for the treatment of acute bacterial maxillary sinusitis: a review of a new antibacterial agent.
Topics: Acute Disease; Adolescent; Adult; Aged; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacteria | 2005 |
Cefuroxime axetil in the treatment of sinusitis. A review.
Topics: Acute Disease; Anti-Bacterial Agents; Bacterial Infections; Cefuroxime; Chronic Disease; Clinical Tr | 1994 |
Short courses of antibiotic in acute otitis media and sinusitis infections.
Topics: Acute Disease; Amoxicillin; Anti-Bacterial Agents; Cefuroxime; Clavulanic Acid; Drug Administration | 2000 |
Review of the experience with cefprozil for the treatment of lower respiratory tract infections.
Topics: Acute Disease; Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; Bronchitis; Bronchopneumo | 1992 |
47 trials available for cefuroxime and Acute Disease
| Article | Year |
|---|---|
Comparison of cefuroxime and co-amoxiclav in the treatment of acute sinusitis in a sample of the Iranian population.
Topics: Acute Disease; Adolescent; Adult; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agen | 2012 |
Open-label, randomized comparison of the efficacy and tolerability of clarithromycin, levofloxacin, and cefuroxime axetil in the treatment of adults with acute bacterial exacerbations of chronic bronchitis.
Topics: Acute Disease; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacterial Infections; Bronchit | 2002 |
Comparison of the efficacy and safety of faropenem daloxate and cefuroxime axetil for the treatment of acute bacterial maxillary sinusitis in adults.
Topics: Acute Disease; Adult; Anti-Bacterial Agents; Bacterial Infections; beta-Lactams; Cefuroxime; Double- | 2003 |
Short-term and long-term outcomes of moxifloxacin compared to standard antibiotic treatment in acute exacerbations of chronic bronchitis.
Topics: Acute Disease; Aged; Amoxicillin; Anti-Bacterial Agents; Aza Compounds; Bronchitis, Chronic; Cefurox | 2004 |
[Estimation the effectiveness of cefuroxime therapy in pediatric otolaryngology].
Topics: Acute Disease; Administration, Oral; Adolescent; Anti-Bacterial Agents; Cefuroxime; Child; Child, Pr | 2004 |
Cefuroxime axetil versus placebo for children with acute respiratory infection and imaging evidence of sinusitis: a randomized, controlled trial.
Topics: Acute Disease; Anti-Bacterial Agents; Cefuroxime; Child; Child, Preschool; Double-Blind Method; Fema | 2005 |
Clinical and bacteriological efficacy in treatment of acute exacerbations of chronic bronchitis with cefditoren-pivoxil versus cefuroxime-axetil.
Topics: Acute Disease; Administration, Oral; Aged; Anti-Bacterial Agents; Bronchitis, Chronic; Cefuroxime; C | 2006 |
Randomized double-blind study comparing 7- and 10-day regimens of faropenem medoxomil with a 10-day cefuroxime axetil regimen for treatment of acute bacterial sinusitis.
Topics: Acute Disease; Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacterial Infectio | 2006 |
Early antibiotic treatment in acute necrotising pancreatitis.
Topics: Acute Disease; Adult; Alcoholism; Bacterial Infections; Cefuroxime; Female; Humans; Male; Middle Age | 1995 |
Cefuroxime efficacy in pneumonia: sequential short-course i.v./oral suspension therapy.
Topics: Acute Disease; Administration, Oral; Cefuroxime; Child, Preschool; Community-Acquired Infections; Dr | 1994 |
Efficacy of cefuroxime axetil suspension compared with that of penicillin V suspension in children with group A streptococcal pharyngitis.
Topics: Acute Disease; Age Factors; Cefuroxime; Child; Child, Preschool; Ethnicity; Female; Humans; Male; Pa | 1993 |
Effectiveness of short-course therapy (5 days) with cefuroxime axetil in treatment of secondary bacterial infections of acute bronchitis.
Topics: Acute Disease; Adolescent; Adult; Aged; Aged, 80 and over; Amoxicillin; Amoxicillin-Potassium Clavul | 1995 |
[Value of antibiotic prophylaxis in acute necrotizing pancreatitis].
Topics: Acute Disease; Adult; Antibiotic Prophylaxis; C-Reactive Protein; Cefuroxime; Cephalosporins; Female | 1996 |
Sparfloxacin versus cefuroxime axetil in the treatment of acute purulent sinusitis. Sinusitis Study Group.
Topics: Acute Disease; Adult; Anti-Infective Agents; Cefuroxime; Cephalosporins; Double-Blind Method; Female | 1996 |
[Early antibiotic treatment in necrotizing acute pancreatitis].
Topics: Acute Disease; Antibiotic Prophylaxis; Bacterial Infections; Cefuroxime; Central Nervous System Depr | 1996 |
Effectiveness of five days of therapy with cefuroxime axetil suspension for treatment of acute otitis media.
Topics: Acute Disease; Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; Cefuroxime; Child; Child, | 1996 |
Impaired bacteriologic response to oral cephalosporins in acute otitis media caused by pneumococci with intermediate resistance to penicillin.
Topics: Acute Disease; Administration, Oral; Cefaclor; Cefuroxime; Cephalosporins; Child, Preschool; Drug Re | 1996 |
[The use of the cephalosporin antibiotic Zinnat under polyclinic conditions in treating patients with bronchopulmonary infections].
Topics: Acute Disease; Adolescent; Adult; Ambulatory Care; Bronchitis; Cefuroxime; Cephalosporins; Chronic D | 1996 |
Bacteriologic response to oral cephalosporins: are established susceptibility breakpoints appropriate in the case of acute otitis media?
Topics: Acute Disease; Administration, Oral; Cefaclor; Cefuroxime; Cephalosporins; Child, Preschool; Female; | 1997 |
Concentration of cefuroxime in middle ear effusion of children with acute otitis media.
Topics: Acute Disease; Administration, Oral; Cefuroxime; Cephalosporins; Child, Preschool; Humans; Infant; M | 1997 |
Ciprofloxacin versus cefuroxime axetil in the treatment of adult patients with acute bacterial sinusitis.
Topics: Acute Disease; Adult; Aged; Analysis of Variance; Anti-Infective Agents; Cefuroxime; Cephalosporins; | 1998 |
Measuring antibiotic levels in otitis media.
Topics: Acute Disease; Administration, Oral; Cefuroxime; Cephalosporins; Child, Preschool; Drug Monitoring; | 1998 |
Randomized, double-blind study of ciprofloxacin and cefuroxime axetil for treatment of acute bacterial exacerbations of chronic bronchitis. The Bronchitis Study Group.
Topics: Acute Disease; Adolescent; Adult; Anti-Infective Agents; Bronchitis; Cefuroxime; Cephalosporins; Chr | 1998 |
Cefuroxime axetil versus clarithromycin in the treatment of acute maxillary sinusitis.
Topics: Absenteeism; Acute Disease; Adult; Anti-Bacterial Agents; Cefuroxime; Cephalosporins; Chi-Square Dis | 1998 |
Ciprofloxacin versus cefuroxime axetil in the treatment of acute bacterial sinusitis. Sinusitis Infection Study Group.
Topics: Acute Disease; Adolescent; Adult; Aged; Cefuroxime; Cephalosporins; Double-Blind Method; Female; Fol | 1999 |
Impact of cefuroxime administration on endotoxin (LPS) and tumour necrosis factor-alpha (TNFalpha) blood levels in patients suffering from acute pyelonephritis: a preliminary report.
Topics: Acute Disease; Aged; Cefuroxime; Cephalosporins; Female; Humans; Lipopolysaccharides; Male; Middle A | 1999 |
Comparison of cefuroxime axetil and amoxicillin/clavulanate in the treatment of acute bacterial sinusitis.
Topics: Acute Disease; Adult; Aged; Amoxicillin-Potassium Clavulanate Combination; Cefuroxime; Cephalosporin | 1999 |
Short course therapy with cefuroxime axetil for acute otitis media: results of a randomized multicenter comparison with amoxicillin/clavulanate.
Topics: Acute Disease; Amoxicillin-Potassium Clavulanate Combination; Bacterial Infections; Cefuroxime; Ceph | 1999 |
Comparison of moxifloxacin and cefuroxime axetil in the treatment of acute maxillary sinusitis. Sinusitis Infection Study Group.
Topics: Acute Disease; Adolescent; Adult; Aged; Anti-Infective Agents; Aza Compounds; Cefuroxime; Cephalospo | 1999 |
A comparison of the safety and efficacy of moxifloxacin (BAY 12-8039) and cefuroxime axetil in the treatment of acute bacterial sinusitis in adults. The Sinusitis Study Group.
Topics: Acute Disease; Adult; Anti-Infective Agents; Aza Compounds; Bacterial Infections; Cefuroxime; Cephal | 2000 |
Efficacy and tolerability of myrtol standardized in acute bronchitis. A multi-centre, randomised, double-blind, placebo-controlled parallel group clinical trial vs. cefuroxime and ambroxol.
Topics: Acute Disease; Adolescent; Adult; Aged; Ambroxol; Bronchitis; Bronchodilator Agents; Cefuroxime; Cep | 2000 |
[Prospective, randomized, comparative study of the efficacy, safety and cost of cefuroxime versus cephradine in acute pyelonephritis during pregnancy].
Topics: Acute Disease; Analysis of Variance; Cefuroxime; Cephalosporins; Cephradine; Cost-Benefit Analysis; | 2000 |
Comparative trial to evaluate the efficacy and tolerability of cefuroxime 250mg with probenecid 250mg with cefuroxime 500mg in the management of community acquired pneumonia, acute bronchitis and acute exacerbation of chronic bronchitis.
Topics: Acute Disease; Adult; Bronchitis; Cefuroxime; Cephalosporins; Community-Acquired Infections; Drug Th | 2000 |
Ecological effects on the oro- and nasopharyngeal microflora in children after treatment of acute otitis media with cefuroxime axetil or amoxycillin-clavulanate as suspensions.
Topics: Acute Disease; Amoxicillin-Potassium Clavulanate Combination; beta-Lactamases; Cefuroxime; Cephalosp | 2001 |
Fewer bacterial relapses after oral treatment with norfloxacin than with ceftibuten in acute pyelonephritis initially treated with intravenous cefuroxime.
Topics: Acute Disease; Administration, Oral; Adult; Aged; Aged, 80 and over; Anti-Infective Agents; Ceftibut | 2001 |
Symptom resolution assessed using a patient directed diary card during treatment of acute exacerbations of chronic bronchitis.
Topics: Acute Disease; Adult; Aged; Aged, 80 and over; Analysis of Variance; Androstadienes; Anti-Inflammato | 2001 |
Comparison of cefuroxime with or without intranasal fluticasone for the treatment of rhinosinusitis. The CAFFS Trial: a randomized controlled trial.
Topics: Acute Disease; Administration, Intranasal; Adult; Androstadienes; Anti-Inflammatory Agents; Cefuroxi | 2001 |
Cefuroxime axetil in the treatment of acute otitis media in children.
Topics: Acute Disease; Amoxicillin; Cefuroxime; Child; Child, Preschool; Female; Humans; Male; Otitis Media; | 1992 |
Clinical comparison of cefuroxime axetil and amoxicillin/clavulanate in the treatment of patients with acute bacterial maxillary sinusitis.
Topics: Acute Disease; Adult; Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; Cefuroxime; Clavul | 1992 |
Review of the experience with cefprozil for the treatment of lower respiratory tract infections.
Topics: Acute Disease; Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; Bronchitis; Bronchopneumo | 1992 |
Piperacillin compared with cefuroxime plus metronidazole in diffuse peritonitis.
Topics: Acute Disease; Adolescent; Adult; Aged; Aged, 80 and over; Cefuroxime; Drug Therapy, Combination; Fe | 1991 |
[Clinical evaluation of cefuroxime axetil in acute dental infections. Double blind comparative study vs. cefaclor].
Topics: Acute Disease; Adolescent; Adult; Aged; Bacteria; Bacterial Infections; Cefaclor; Cefuroxime; Double | 1990 |
[Ambulatory treatment with cefuroxime-axetil of infectious bronchitis in patients sixty years of age or older: comparative study of the combination of amoxicillin and clavulanic acid].
Topics: Acute Disease; Aged; Ambulatory Care; Amoxicillin; Bronchitis; Cefuroxime; Cephalosporins; Clavulani | 1990 |
Comparison of cefuroxime axetil, cefaclor, and amoxicillin-clavulanate potassium suspensions in acute otitis media in infants and children.
Topics: Acoustic Impedance Tests; Acute Disease; Administration, Oral; Amoxicillin; Amoxicillin-Potassium Cl | 1990 |
Single-dose cefuroxime axetil versus multiple-dose cefaclor in the treatment of acute urinary tract infections.
Topics: Acute Disease; Adult; Blood Chemical Analysis; Cefaclor; Cefuroxime; Cephalexin; Cephalosporins; Fem | 1989 |
Treatment of otitis media with cefuroxime axetil.
Topics: Acute Disease; Cefaclor; Cefuroxime; Cephalosporins; Child; Child, Preschool; Clinical Trials as Top | 1988 |
Blinded comparison of cefuroxime to cefaclor for lower respiratory tract infections.
Topics: Acute Disease; Administration, Oral; Adult; Aged; Bacterial Infections; Bronchitis; Cefaclor; Cefuro | 1988 |
57 other studies available for cefuroxime and Acute Disease
| Article | Year |
|---|---|
A Cohort Study of Risk Factors That Influence Empirical Treatment of Patients with Acute Pyelonephritis.
Topics: Acute Disease; Adult; Aged; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Ce | 2017 |
ACUTE MACULAR EDEMA WITH SEROUS RETINAL DETACHMENT AFTER CATARACT SURGERY IN A VITRECTOMIZED EYE: A CASE REPORT.
Topics: Acute Disease; Cataract Extraction; Cefuroxime; Female; Humans; Macular Edema; Middle Aged; Retinal | 2021 |
The management of acute mastoiditis in children with cochlear implants: saving the device.
Topics: Acute Disease; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Cefprozil; Cefu | 2013 |
Nonoperative management of perforated diverticulitis with extraluminal air is safe and effective in selected patients.
Topics: Acute Disease; Administration, Intravenous; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; C | 2014 |
A prospective, observational, epidemiological evaluation of the aetiology and antimicrobial susceptibility of acute otitis media in Saudi children younger than 5years of age.
Topics: Acute Disease; Anti-Bacterial Agents; Cefotaxime; Cefuroxime; Child, Preschool; Drug Resistance, Mul | 2014 |
Propensity-matched analysis to compare the therapeutic efficacies of cefuroxime versus cefotaxime as initial antimicrobial therapy for community-onset complicated nonobstructive acute pyelonephritis due to Enterobacteriaceae infection in women.
Topics: Acute Disease; Aged; Anti-Bacterial Agents; Cefotaxime; Cefuroxime; Community-Acquired Infections; E | 2015 |
[Study on pharmacokinetics of cefuroxime by dynamics of its distribution in oral fluid of patients with sinusitis].
Topics: Acute Disease; Adolescent; Anti-Bacterial Agents; Cefuroxime; Female; Humans; Male; Saliva; Sensitiv | 2014 |
Incidence of Acute Postoperative Endophthalmitis after Cataract Surgery: A Nationwide Study in France from 2005 to 2014.
Topics: Acute Disease; Adult; Age Distribution; Aged; Aged, 80 and over; Anti-Bacterial Agents; Cefuroxime; | 2016 |
Antibiotic prophylaxis in severe acute pancreatitis: do we need more meta-analytic studies?
Topics: Acute Disease; Antibiotic Prophylaxis; Carbapenems; Cefuroxime; Ciprofloxacin; Humans; Meta-Analysis | 2009 |
In vitro antimicrobial activity of cefditoren and other oral antibiotics against Streptococcus pneumoniae, isolated from children with community acquired respiratory tract infections.
Topics: Acute Disease; Amoxicillin; Anti-Bacterial Agents; Cefaclor; Cefdinir; Cefuroxime; Cephalosporins; C | 2010 |
[Endophthalmitis after cataract surgery: epidemiology, clinical features and antibiotic prophylaxis].
Topics: Acute Disease; Aged; Aged, 80 and over; Anterior Chamber; Anti-Bacterial Agents; Antibiotic Prophyla | 2010 |
Acute mastoiditis caused by Moraxella catarrhalis.
Topics: Acute Disease; Anti-Bacterial Agents; Cefuroxime; Child, Preschool; Female; Gram-Negative Bacterial | 2003 |
[Acute exacerbated chronic bronchitis. Antibiotics in comparison].
Topics: Acute Disease; Amoxicillin; Anti-Bacterial Agents; Aza Compounds; Bronchitis, Chronic; Cefuroxime; C | 2003 |
[Pharmacoeconomic analysis of patients with acute exacerbation of chronic bronchitis treated with telithromycin or cefuroxime-axetil].
Topics: Acute Disease; Algorithms; Anti-Bacterial Agents; Bronchitis, Chronic; Cefuroxime; Cost-Benefit Anal | 2004 |
[Preseptal and orbital cellulitis in childhood: response to intravenous antibiotics].
Topics: Acute Disease; Anti-Bacterial Agents; Cefotaxime; Cefuroxime; Cellulitis; Child; Child, Preschool; D | 2005 |
Cefuroxime axetil in the treatment of acute bronchitis in UK general practice.
Topics: Acute Disease; Adolescent; Adult; Anti-Bacterial Agents; Bronchitis; Cefuroxime; Clinical Trials as | 1989 |
A comparative trial of cefuroxime axetil and ampicillin plus probenecid in the treatment of acute gonococcal infection.
Topics: Acute Disease; Ampicillin; Anti-Bacterial Agents; Cefuroxime; Clinical Trials as Topic; Drug Therapy | 1989 |
Influence of the beta-lactam resistance phenotype on the cefuroxime versus cefditoren susceptibility of Streptococcus pneumoniae and Haemophilus influenzae recovered from children with acute otitis media.
Topics: Acute Disease; Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamases; Cefuroxime; Cephalosp | 2007 |
Cefuroxime for Acinetobacter infection.
Topics: Acinetobacter Infections; Acute Disease; Cefuroxime; Cephalosporins; Humans; Pneumonia | 1981 |
Single dose treatment of acute gonorrhoea with Cefuroxime: experience from Zaria, Nigeria.
Topics: Acute Disease; Cefuroxime; Cephalosporins; Gonorrhea; Humans; Nigeria | 1983 |
[In vitro action and therapeutic evaluation of cefuroxime in acute bacterial infections in pediatrics].
Topics: Acute Disease; Adolescent; Bacterial Infections; Cefuroxime; Cephalosporins; Child; Child, Preschool | 1983 |
Cefuroxime in acute septic arthritis.
Topics: Acinetobacter Infections; Acute Disease; Arthritis, Infectious; Cefuroxime; Cephalosporins; Drug Eva | 1984 |
Benefits and risks of sequential parenteral--oral cephalosporin therapy for suppurative bone and joint infections.
Topics: Acute Disease; Administration, Oral; Arthritis, Infectious; Bacterial Infections; Cefaclor; Cefamand | 1982 |
Early antibiotic treatment in acute necrotising pancreatitis.
Topics: Acute Disease; Anti-Bacterial Agents; Cefuroxime; Cephalosporins; Humans; Necrosis; Pancreatitis; St | 1995 |
Early antibiotic treatment in acute necrotising pancreatitis.
Topics: Acute Disease; Anti-Bacterial Agents; Cefuroxime; Cephalosporins; Drug Resistance, Microbial; Humans | 1995 |
In vivo correlates for Streptococcus pneumoniae penicillin resistance in acute otitis media.
Topics: Acute Disease; Cefuroxime; Child, Preschool; Humans; Infant; Microbial Sensitivity Tests; Otitis Med | 1995 |
Changed clinical course and current treatment of acute epiglottitis in adults a 12-year experience.
Topics: Acute Disease; Adolescent; Adult; Cefuroxime; Epiglottitis; Female; Finland; Humans; Male; Middle Ag | 1994 |
Acute arthritis of the hip in a child infected with the Lyme spirochete.
Topics: Acute Disease; Antibodies, Bacterial; Arthritis, Infectious; Borrelia burgdorferi Group; Cefuroxime; | 1993 |
[Clinical observation of oral cefuroxime axetil for treating acute gonorrhoea].
Topics: Acute Disease; Administration, Oral; Adult; Cefuroxime; Cephalosporins; Female; Gonorrhea; Humans; M | 1995 |
Acute brucellosis associated with massive proteinuria.
Topics: Acute Disease; Brucellosis; Cefuroxime; Cephalosporins; Diabetes Mellitus, Type 2; Female; Humans; K | 1996 |
Antibiotic prophylaxis in severe acute pancreatitis.
Topics: Acute Disease; Antibiotic Prophylaxis; Cefotaxime; Cefuroxime; Cephalosporins; Humans; Pancreatitis; | 1996 |
Acute lingual tonsillitis.
Topics: Acute Disease; Airway Obstruction; Cefuroxime; Cephalosporins; Female; Humans; Laryngoscopy; Middle | 1997 |
Retropharyngeal abscess and acute torticollis.
Topics: Acute Disease; Anti-Bacterial Agents; Anti-Inflammatory Agents, Non-Steroidal; Antitrichomonal Agent | 1997 |
Facial nerve paralysis in acute otitis media: cause and management revisited.
Topics: Acute Disease; Adult; Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Age | 1998 |
In vivo efficacies of amoxicillin and cefuroxime against penicillin-resistant Streptococcus pneumoniae in a gerbil model of acute otitis media.
Topics: Acute Disease; Amoxicillin; Animals; Cefuroxime; Disease Models, Animal; Drug Therapy, Combination; | 1998 |
Suppurative parotitis.
Topics: Acute Disease; Adult; Amphotericin B; Candidiasis; Cefuroxime; Cephalosporins; Humans; Infusions, In | 1998 |
[Zinnat in ambulatory treatment of acute pharyngitis and otitis media in adult patients].
Topics: Acute Disease; Adult; Ambulatory Care; Cefuroxime; Cephalosporins; Female; Humans; Male; Otitis Medi | 1997 |
[Development of resistance to beta-lactams and other antibiotics of pneumococci isolated from acute otitis media in France: statement of the National Reference Center 1995-1996].
Topics: Acute Disease; Amoxicillin; beta-Lactam Resistance; beta-Lactams; Cefpodoxime; Ceftizoxime; Cefuroxi | 1998 |
The infection-free interval: its use in evaluating antimicrobial treatment of acute exacerbation of chronic bronchitis.
Topics: Acute Disease; Bacterial Infections; Bronchitis; Cefuroxime; Ciprofloxacin; Clarithromycin; Humans; | 1999 |
Role of Streptococcus pneumoniae and Haemophilus influenzae in the development of acute otitis media and otitis media with effusion in a gerbil model.
Topics: Acute Disease; Amoxicillin-Potassium Clavulanate Combination; Animals; Cefuroxime; Cephalosporins; C | 2000 |
Assessment of antibiotic prescription in acute respiratory infections in adults. The Spanish Study Group on Antibiotic Treatments.
Topics: Acute Disease; Adolescent; Adult; Aged; Aged, 80 and over; Amoxicillin-Potassium Clavulanate Combina | 2000 |
The variability and appropriateness of the antibiotic prescription of acute otitis media in childhood. The Spanish Study Group for Antibiotic Treatments.
Topics: Acute Disease; Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Ce | 2000 |
Acute generalized exanthematous pustulosis mimicking toxic epidermal necrolysis.
Topics: Acetaminophen; Acute Disease; Aged; Aged, 80 and over; Analgesics, Non-Narcotic; Cefuroxime; Cephalo | 2001 |
[Comparative clinical efficacy and tolerance of cefuroxime axetil (zinnat) and ceftibuten (cedex) in patients with acute sinusitis].
Topics: Acute Disease; Adult; Ceftibuten; Cefuroxime; Cephalosporins; Drug Tolerance; Female; Humans; Male; | 2001 |
[Treatment of acute otitis media in children].
Topics: Acute Disease; Age Factors; Amoxicillin; Analgesics; Analgesics, Non-Narcotic; Anti-Bacterial Agents | 1998 |
[Therapeutic efficacy assessment of cefuroxime axetil in short 4 day course of empirical antibiotic therapy in patients with bacterial infections of upper respiratory tract and otitis media].
Topics: Acute Disease; Administration, Oral; Adult; Cefuroxime; Cephalosporins; Drug Administration Schedule | 2001 |
Do intranasal corticosteroids aid treatment of acute sinusitis in patients with a history of recurrent sinus symptoms?
Topics: Acute Disease; Administration, Intranasal; Adult; Androstadienes; Anti-Inflammatory Agents; Cefuroxi | 2002 |
Concentration of cefuroxime in serum and middle ear effusion after single dose treatment with cefuroxime axetil.
Topics: Acute Disease; Administration, Oral; Cefuroxime; Child; Chronic Disease; Exudates and Transudates; F | 1991 |
Acute prostatitis: which antibiotic to use first.
Topics: Acute Disease; Anti-Bacterial Agents; Aztreonam; Cefuroxime; Humans; Male; Netilmicin; Prostate; Pro | 1990 |
Comparative evaluation of cefuroxime axetil and cefaclor for treatment of acute bacterial maxillary sinusitis.
Topics: Acute Disease; Adult; Aged; Bacterial Infections; beta-Lactamases; Cefaclor; Cefuroxime; Cephalexin; | 1989 |
Treatment of acute uncomplicated urinary tract infections with single daily doses of cefuroxime axetil.
Topics: Acute Disease; Cefuroxime; Cephalosporins; Female; Humans; Urinary Tract Infections | 1989 |
[Fever induced by cefuroxime].
Topics: Acute Disease; Cefuroxime; Cephalosporins; Child; Female; Fever; Humans; Pancreatitis | 1989 |
Clinical trial of cefuroxime axetil in children.
Topics: Acute Disease; Adolescent; Cefuroxime; Cephalosporins; Child; Child, Preschool; Female; Haemophilus | 1987 |
[Clinical studies on cefuroxime axetil in acute mastitis].
Topics: Acute Disease; Adult; Cefuroxime; Cephalosporins; Drug Evaluation; Drug Resistance, Microbial; Femal | 1987 |
Predisposing factors, bacteriology and antibiotic therapy in 35 cases of septic bursitis.
Topics: Acute Disease; Adult; Aged; Aged, 80 and over; Bacterial Infections; Bursitis; Cefuroxime; Diabetes | 1986 |
[Pharmacokinetics of cefuroxime in pregnant women with acute pyelonephritis].
Topics: Acute Disease; Adolescent; Adult; Biological Availability; Cefuroxime; Cephalosporins; Female; Half- | 1985 |
Acute and exacerbated chronic respiratory tract infections: treatment with a combination of cefuroxime and acetylcysteine.
Topics: Acetylcysteine; Acute Disease; Adolescent; Adult; Aged; Cefuroxime; Cephalosporins; Chronic Disease; | 1985 |